De La Garza R, 2nd

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Rivastigmine does not alter cocaine-induced subjective effects or self-administration - Patel_2019_Pharmacol.Biochem.Behav__172758
Author(s) : Patel M , Verrico CD , De La Garza R, 2nd
Ref : Pharmacol Biochem Behav , :172758 , 2019
Abstract : Patel_2019_Pharmacol.Biochem.Behav__172758
ESTHER : Patel_2019_Pharmacol.Biochem.Behav__172758
PubMedSearch : Patel_2019_Pharmacol.Biochem.Behav__172758
PubMedID: 31430484

Title : Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder - De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
Author(s) : De La Garza R, 2nd , Verrico CD , Newton TF , Mahoney JJ, 3rd , Thompson-Lake DG
Ref : Int J Neuropsychopharmacol , 19 :pyv098 , 2016
Abstract : De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
ESTHER : De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
PubMedSearch : De La Garza_2016_Int.J.Neuropsychopharmacol_19_pyv098
PubMedID: 26364275

Title : Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers - Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
Author(s) : Mahoney JJ, 3rd , Kalechstein AD , Verrico CD , Arnoudse NM , Shapiro BA , De La Garza R, 2nd
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 50 :137 , 2014
Abstract : Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
ESTHER : Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
PubMedSearch : Mahoney_2014_Prog.Neuropsychopharmacol.Biol.Psychiatry_50_137
PubMedID: 24239594

Title : Rivastigmine reduces Likely to use methamphetamine in methamphetamine-dependent volunteers - De La Garza_2012_Prog.Neuropsychopharmacol.Biol.Psychiatry_37_141
Author(s) : De La Garza R, 2nd , Newton TF , Haile CN , Yoon JH , Nerumalla CS , Mahoney JJ, 3rd , Aziziyeh A
Ref : Prog Neuropsychopharmacol Biological Psychiatry , 37 :141 , 2012
Abstract : De La Garza_2012_Prog.Neuropsychopharmacol.Biol.Psychiatry_37_141
ESTHER : De La Garza_2012_Prog.Neuropsychopharmacol.Biol.Psychiatry_37_141
PubMedSearch : De La Garza_2012_Prog.Neuropsychopharmacol.Biol.Psychiatry_37_141
PubMedID: 22230648

Title : Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals - Kalechstein_2011_Pharmacol.Biochem.Behav_99_423
Author(s) : Kalechstein AD , Yoon JH , Croft DE , Jaeggi S , Mahoney JJ, 3rd , De La Garza R, 2nd
Ref : Pharmacol Biochem Behav , 99 :423 , 2011
Abstract : Kalechstein_2011_Pharmacol.Biochem.Behav_99_423
ESTHER : Kalechstein_2011_Pharmacol.Biochem.Behav_99_423
PubMedSearch : Kalechstein_2011_Pharmacol.Biochem.Behav_99_423
PubMedID: 21624391

Title : Pilot Safety Evaluation of Varenicline for the Treatment of Methamphetamine Dependence - Zorick_2009_J.Exp.Pharmacol_2010_13
Author(s) : Zorick T , Sevak RJ , Miotto K , Shoptaw S , Swanson AN , Clement C , De La Garza R, 2nd , Newton TF , London ED
Ref : J Exp Pharmacol , 2010 :13 , 2009
Abstract : Zorick_2009_J.Exp.Pharmacol_2010_13
ESTHER : Zorick_2009_J.Exp.Pharmacol_2010_13
PubMedSearch : Zorick_2009_J.Exp.Pharmacol_2010_13
PubMedID: 20689642

Title : The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers - De La Garza_2008_Pharmacol.Biochem.Behav_89_200
Author(s) : De La Garza R, 2nd , Mahoney JJ, 3rd , Culbertson C , Shoptaw S , Newton TF
Ref : Pharmacol Biochem Behav , 89 :200 , 2008
Abstract : De La Garza_2008_Pharmacol.Biochem.Behav_89_200
ESTHER : De La Garza_2008_Pharmacol.Biochem.Behav_89_200
PubMedSearch : De La Garza_2008_Pharmacol.Biochem.Behav_89_200
PubMedID: 18207225